Skip to content
Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article Psyched Wellness Closes $6,603,000 Bought Deal Private Placement

Psyched Wellness Closes $6,603,000 Bought Deal Private Placement

  • Post published:February 17, 2021
  • Post category:Press Release
Read more about the article Revive Therapeutics Acquires Unique Psilocybin Assets

Revive Therapeutics Acquires Unique Psilocybin Assets

  • Post published:February 17, 2021
  • Post category:Press Release
Read more about the article PharmaTher Announces Sale of Psilocybin Program

PharmaTher Announces Sale of Psilocybin Program

  • Post published:February 17, 2021
  • Post category:Press Release
Read more about the article Tryp Therapeutics Completes $2 Million Strategic Financing

Tryp Therapeutics Completes $2 Million Strategic Financing

  • Post published:February 17, 2021
  • Post category:Press Release
Read more about the article Mind Cure Comments on Recent Promotional Activity

Mind Cure Comments on Recent Promotional Activity

  • Post published:February 17, 2021
  • Post category:Press Release
Read more about the article MindMed’s LSD Neutralizer Study Begins

MindMed’s LSD Neutralizer Study Begins

  • Post published:February 17, 2021
  • Post category:Press Release
Read more about the article Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap’s Mental Health Technology

Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap’s Mental Health Technology

  • Post published:February 17, 2021
  • Post category:Press Release
Read more about the article Field Trip Health Ltd. Reports Third Fiscal Quarter 2021 Financial Results

Field Trip Health Ltd. Reports Third Fiscal Quarter 2021 Financial Results

  • Post published:February 16, 2021
  • Post category:Press Release
Read more about the article Tryp Therapeutics Launches Clinical Trials to Investigate Psilocybin for Over-Eating Disorders

Tryp Therapeutics Launches Clinical Trials to Investigate Psilocybin for Over-Eating Disorders

  • Post published:February 16, 2021
  • Post category:Analysis/Editorial
Read more about the article Alberta’s First Full-Service Psychedelic Therapy Clinic Opens in Calgary, Ushering in a New Era of Hope to Deal with the Growing Mental Health Crisis in Canada

Alberta’s First Full-Service Psychedelic Therapy Clinic Opens in Calgary, Ushering in a New Era of Hope to Deal with the Growing Mental Health Crisis in Canada

  • Post published:February 16, 2021
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2026, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More